The demand for efficient diagnostic and screening methods has increased due to an increase in breast cancer cases worldwide. The global molecular breast imaging market was driven by this factor to reach US$ 846.7 million in 2022, and it is anticipated to grow at a 4.8% CAGR from 2023 to 2033.Molecular breast imaging.
Scientists at Lawrence Livermore National Laboratory (LLNL) collaborated with University of California San Diego (UCSD) to design, assemble, and field a portable optical Thomson scattering diagnostic system for the Advanced